USD10
RNAC delen
Info over Cartesian TherapeuticsCartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.
USD10
RNAC delen
Info over Cartesian TherapeuticsCartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.
Statistieken
HANDELSVENSTER
Gesloten
OPENT OM
Onvoldoende gegevens
MARKTKAPITALISATIE
US$ 169,28 mln.
OPENINGSPRIJS
US$ 6,53
LAAG (1J)
US$ 5,98
HOOG (1J)
US$ 16,62
LAAG (24u)
US$ 6,36
HOOG (24H)
US$ 6,72
VOLUME (24 uur)
US$ 106,54K
4,39%
Prijsgeschiedenis
Time | Price | Change |
|---|---|---|
Vandaag | US$ 6,53 | |
1 dag | US$ 6,69 | |
1 week | US$ 7,76 | |
1 maand | US$ 7,07 | |
1 jaar | US$ 15,94 |